1-833-663-7284 (Customer Support Available 24/7)
by Kat Helgeson
Until now, cannabis research has largely been the province of specialists at universities. That’s a good thing because university research is beneficial not only to society—as discoveries are made about the properties of cannabis and its potential uses—but to the universities as well. When a university study is successful, that can mean funding for that university, and that helps the institution remain operational. And as we all know, universities are where we get more scientists, with more research ideas that open more doors for future cannabis potential.
That said, private research performed by companies has its benefits too. In general, private companies have more funds to devote to research. They are also usually more specialized, able to dedicate their entire staff and research budget to one issue, where universities are forced by their nature to diversify widely.
Now, the private company Ethos Cannabis has teamed up with Thomas Jefferson University in Pennsylvania, bringing the best of both worlds to their new cannabis study.
Ethos Cannabis prides itself on being more than just a dispensary. Their mission is to improve their patients’ health—and not only that but to provide an understanding of how cannabis is helping. With locations in Pennsylvania and Massachusetts, this growing company encourages people to come in and ask questions and not to feel intimidated by the process. They strive for an environment that is friendly rather than clinical, where patients can feel supported and can gain an understanding of the benefits of cannabis, whether they are using it medically or recreationally. Ethos Cannabis believes that everyone has a right to choose how they feel, and that cannabis can help.
With their new partnership, Ethos Cannabis has become the first-ever private company to receive a clinical research partnership license.
Now that they have teamed up, Ethos Cannabis and Thomas Jefferson University have two research programs currently underway.
The first study is a focus group designed to explore individuals’ experiences with obtaining medical cannabis. Volunteers for the study will be asked to report on the process of obtaining a medical cannabis license, as well as what happened when they actually visited a dispensary. The information obtained from the study will be used to improve the education offered to patients about their medical cannabis options and to better prepare them for the process of obtaining medical cannabis.
The second study focuses on patients with serious illnesses who are experiencing symptoms that negatively impact their quality of life. The goal of the study is to discover whether cannabis is effective at managing specific symptoms—and if so, which symptoms, and what dosages are appropriate to experience the desired effects.
Participants in the study will be monitored over the course of a year, during which they will use cannabis to try to manage their symptoms. Every three months, participants will be asked to complete a survey regarding their experiences. The questionnaire will deal with their symptoms and how the use of medical cannabis has affected the way they feel.
The partnership between Ethos Cannabis and Thomas Jefferson University will hopefully be just the first of many strong team-ups between private companies and research universities. With two such strong and dedicated entities working together for a common goal, great strides are sure to be made. It is teamwork like this that will lead to the next phase in cannabis legalization and availability, and we have reason to hope that before long everyone who needs medical cannabis will be able to access it easily and that many more effective uses of medical cannabis will be discovered.
In 2018, former President Donald Trump signed the Farm Bill into law. The Farm Bill is the federal government’s primary agricultural and food policy instrument. Every five years, Congress deals with renewing and revising the comprehensive bill. Before 2018, cannabis was not part of the conversation around farm subsidies or crop insurance. With the passing…
Four U.S. states—Minnesota, Ohio, Oklahoma, and Pennsylvania—stand a good chance at legalizing recreational cannabis this year. There’s also a slim chance of efforts being successfully voted on in the Carolinas, Indiana, and New Hampshire. Advocates are pushing harder for cannabis reform after achieving mixed results during last year’s midterm elections, which saw two victories (Missouri…
Nobody wants to spend time with paranoid Pete, but if you don’t choose your cannabis strains wisely, you could get flung into a portal of paranoia yourself. Funnily enough, a recent Marist poll found that almost a third of cannabis users in the U.S. use marijuana to ease anxiety or stress. A separate Marist poll…
Thursday, Jan. 26, 2023, will be a date to remember for cannabis lobbyists in Greece because, on this day, the first-ever medicinal cannabis production plant was inaugurated at Examilia in Corinth. Drizzled in seaside charm, Corinth is renowned for its ancient Roman remains and now claims the limelight as a medical marijuana production hub. Tikun…
Oklahomans’ cannabis vote ended on a sour note, a Canadian dispensary is facing backlash over cocaine sales, and Arizona law students are offering free expungement services. Let’s dive into this week’s cannanews. Oklahomans Vote on Cannabis Legalization Earlier this week, Oklahoma voters had a big decision to make on the ballot. Question 820 asked Oklahomans…
Cannabis patients’ right to own a gun has been in question since cannabis legalization kicked off. Despite the fact that consumers of…
Vaping cannabis has increased in popularity over the last decade. It wasn’t long ago that many people weren’t familiar with vaping, but…
Pancakes are an essential part of any great breakfast. We’ve all probably had blueberry, strawberry, and even banana pancakes—but how about adding…
